Subtopic Deep Dive

← Synthesis and bioactivity of alkaloids

Alkaloids DNA Binding Mechanisms
Research Guide

What is Alkaloids DNA Binding Mechanisms?

Alkaloids DNA binding mechanisms describe how beta-carboline alkaloids like harmine interact with DNA through groove binding, intercalation, and topoisomerase inhibition, as studied via spectroscopy and cytotoxicity assays.

Beta-carbolines from Peganum harmala exhibit antitumor activity by inhibiting DNA topoisomerase I and II (Madadkar-Sobhani et al., 2002, 132 citations; Funayama et al., 1996, 126 citations). 9-substituted harmine derivatives show structure-dependent DNA binding affinities (Cao et al., 2005, 158 citations). Harmine derivatives correlate DNA interactions with cytotoxic potency (Chen et al., 2004, 160 citations). Over 10 key papers span 1996-2023.

Curated Papers

Key Challenges

Why It Matters

These mechanisms enable rational design of anticancer agents targeting DNA topology dysregulation (Yakkala et al., 2023). Beta-carboline topoisomerase inhibition by Peganum harmala extracts guides drug lead discovery from plants (Madadkar-Sobhani et al., 2002). Structure-activity relationships of harmine derivatives link DNA binding strength to tumor cell cytotoxicity (Chen et al., 2004; Cao et al., 2005). Findings support development of novel derivatives like DH334 for CDK inhibition in cancer therapy (Li et al., 2007).

Key Research Challenges

Quantifying binding modes

Distinguishing groove binding from intercalation requires advanced spectroscopy, as harmine derivatives show varied affinities (Cao et al., 2005). Crystallography data remains limited for beta-carboline-DNA complexes. Correlating in vitro binding with cellular potency challenges rational design (Chen et al., 2004).

Topoisomerase selectivity

Beta-carbolines inhibit both topo I and II, complicating specificity for anticancer targeting (Funayama et al., 1996; Deveau et al., 2001). Neurotoxic side effects limit therapeutic windows (Chen et al., 2004). Synthetic derivatives need optimization for selective inhibition (Madadkar-Sobhani et al., 2002).

Structure-activity prediction

Predicting cytotoxic potency from DNA binding remains empirical despite SAR studies on 9-substituted harmines (Cao et al., 2005). Functionalization like amino-acid β-carbolines alters topo II inhibition unpredictably (Deveau et al., 2001). Integrating membrane interactions adds complexity (Tsuchiya, 2015).

Essential Papers

Membrane Interactions of Phytochemicals as Their Molecular Mechanism Applicable to the Discovery of Drug Leads from Plants

Hironori Tsuchiya · 2015 · Molecules · 217 citations

In addition to interacting with functional proteins such as receptors, ion channels, and enzymes, a variety of drugs mechanistically act on membrane lipids to change the physicochemical properties ...

Antitumor and neurotoxic effects of novel harmine derivatives and structure‐activity relationship analysis

Qi Chen, Rihui Chao, Hongsheng Chen et al. · 2004 · International Journal of Cancer · 160 citations

Abstract Beta‐carboline alkaloids such as harmine are present in medicinal plants such as Peganum harmala that have been used as folk medicine in anticancer therapy. In our study, 9 harmine derivat...

DNA binding properties of 9-substituted harmine derivatives

Rihui Cao, Wenlie Peng, Hongsheng Chen et al. · 2005 · Biochemical and Biophysical Research Communications · 158 citations

An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids.

Armin Madadkar‐Sobhani, Sultan-Ahmad Ebrahimi, Massoud Mahmoudian · 2002 · PubMed · 132 citations

Our in vitro findings demonstrate that P. harmala seeds extract do inhibit human DNA topoisomerase I and based on the results of HPTLC analysis, it appears that the biological activity of the extra...

Effects of β- and γ-carboline derivatives on DNA topoisomerase activities

Yasunori Funayama, Kazuto Nishio, Keiji Wakabayashi et al. · 1996 · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 126 citations

The synthesis of amino-acid functionalized β-Carbolines as topoisomerase II inhibitors

Amy M. Deveau, Marc Labroli, Christine M. Dieckhaus et al. · 2001 · Bioorganic & Medicinal Chemistry Letters · 102 citations

Alkaloids Induce Programmed Cell Death in Bloodstream Forms of Trypanosomes (Trypanosoma b. brucei)

Vera Rosenkranz, Michaël Wink · 2008 · Molecules · 90 citations

The potential induction of a programmed cell death (PCD) in Trypanosoma b. brucei by 55 alkaloids of the quinoline, quinolizidine, isoquinoline, indole, terpene, tropane, steroid, and piperidine ty...

Reading Guide

Foundational Papers

Start with Chen et al. (2004, 160 citations) for harmine antitumor SAR, Cao et al. (2005, 158 citations) for DNA binding properties, and Madadkar-Sobhani et al. (2002, 132 citations) for topo I inhibition by Peganum harmala extracts.

Recent Advances

Study Yakkala et al. (2023) for topo inhibitor prospects and Tsuchiya (2015, 217 citations) for membrane-DNA interactions in drug leads.

Core Methods

Spectroscopy for binding modes (Cao et al., 2005), in vitro topo assays (Funayama et al., 1996; Madadkar-Sobhani et al., 2002), and cytotoxicity SAR (Chen et al., 2004).

How PapersFlow Helps You Research Alkaloids DNA Binding Mechanisms

Discover & Search

Research Agent uses searchPapers('beta-carboline DNA intercalation') to retrieve Cao et al. (2005, 158 citations), then citationGraph reveals clusters around Chen et al. (2004) and Funayama et al. (1996); findSimilarPapers expands to topoisomerase inhibitors; exaSearch uncovers niche spectroscopy studies.

Analyze & Verify

Analysis Agent applies readPaperContent on Cao et al. (2005) to extract binding constants, verifyResponse with CoVe cross-checks intercalation claims against Funayama et al. (1996), and runPythonAnalysis plots SAR data from Chen et al. (2004) using matplotlib for affinity vs. cytotoxicity; GRADE assigns high evidence to topo inhibition (Madadkar-Sobhani et al., 2002).

Synthesize & Write

Synthesis Agent detects gaps in topo II selectivity from Deveau et al. (2001) vs. harmine SAR (Cao et al., 2005), flags contradictions in neurotoxicity (Chen et al., 2004); Writing Agent uses latexEditText for mechanisms section, latexSyncCitations integrates 10 papers, latexCompile generates PDF, exportMermaid diagrams binding modes.

Use Cases

"Analyze binding affinities from Cao 2005 and plot vs cytotoxicity from Chen 2004"

Research Agent → searchPapers → readPaperContent (extract Kd values) → Analysis Agent → runPythonAnalysis (pandas plot affinity/cytotoxicity correlation) → matplotlib figure of SAR trends.

"Write LaTeX review on beta-carboline topo inhibition with diagrams"

Synthesis Agent → gap detection (selectivity gaps) → Writing Agent → latexEditText (draft section) → latexSyncCitations (add Madadkar-Sobhani 2002) → latexCompile (full PDF) → exportMermaid (intercalation diagram).

"Find GitHub repos with beta-carboline docking simulations"

Research Agent → paperExtractUrls (Deveau 2001) → paperFindGithubRepo (SAR models) → githubRepoInspect (code for topo II binding) → runPythonAnalysis (re-run docking scripts).

Automated Workflows

Deep Research workflow scans 50+ alkaloids papers via searchPapers, structures topo inhibition report with GRADE grading on Madadkar-Sobhani et al. (2002). DeepScan's 7-step chain verifies SAR claims: readPaperContent (Cao 2005) → CoVe → runPythonAnalysis. Theorizer generates hypotheses on groove vs. intercalation from Funayama et al. (1996) citationGraph.

Try Doxa for Alkaloids DNA Binding Mechanisms Research

Frequently Asked Questions

What defines alkaloids DNA binding mechanisms?

Beta-carboline alkaloids bind DNA via groove binding, intercalation, or topoisomerase inhibition, measured by spectroscopy and cytotoxicity (Cao et al., 2005; Funayama et al., 1996).

What methods study these mechanisms?

Spectroscopy quantifies binding affinities, HPTLC identifies active beta-carbolines, and in vitro assays test topo I/II inhibition (Madadkar-Sobhani et al., 2002; Cao et al., 2005).

What are key papers?

Chen et al. (2004, 160 citations) on harmine SAR; Cao et al. (2005, 158 citations) on DNA binding; Madadkar-Sobhani et al. (2002, 132 citations) on topo I inhibition.

What open problems exist?

Achieving topo isoform selectivity, predicting SAR for derivatives, and obtaining DNA-alkaloid crystal structures remain unsolved (Deveau et al., 2001; Chen et al., 2004).